Maze Therapeutics, Inc. - MAZE

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$2.005B
QoQ value delta ($000)
+$890M (+79.82%)
Implied price effect (QoQ)
+59.77%
Shares
Total shares
48,398,962
QoQ shares delta
+5,398,612 (+12.55%)
Total shares held by funds (by quarter)

Market chart (MAZE)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Frazier Life Sciences Management, L.P. 189,222 4,567,274 5.08%
TRV GP IV, LLC 185,356 4,473,958 72.65%
Deep Track Capital, LP 175,930 4,246,440 3.14%
ARCH Venture Management, LLC 170,693 4,120,053 26.19%
JANUS HENDERSON GROUP PLC 130,197 3,142,587 0.06%
BlackRock, Inc. 94,756 2,287,155 0.0%
a16z Capital Management, L.L.C. 70,523 1,702,225 4.46%
VANGUARD GROUP INC 70,307 1,697,015 0.0%
VR Adviser, LLC 64,157 1,548,569 3.17%
Alphabet Inc. 57,528 1,388,583 2.23%
General Catalyst Group Management, LLC 42,917 1,035,910 19.35%
Woodline Partners LP 42,889 1,035,229 0.17%
TRV GP V, LLC 39,391 950,800 9.18%
Logos Global Management LP 39,358 950,000 2.38%
Bellevue Group AG 36,777 887,708 0.7%
MARSHALL WACE, LLP 35,110 847,472 0.03%
ArrowMark Colorado Holdings LLC 31,792 767,383 0.7%
Casdin Capital, LLC 31,439 758,857 1.95%
FMR LLC 30,186 728,605 0.0%
Ikarian Capital, LLC 26,709 644,680 2.09%
Caligan Partners LP 22,794 550,191 1.88%
STATE STREET CORP 22,082 533,005 0.0%
GEODE CAPITAL MANAGEMENT, LLC 21,850 527,281 0.0%
Foresite Capital Management IV, LLC 21,653 522,657 9.43%
Squadron Capital Management LLC 20,300 490,000 8.6%